Elotuzumab, Lenalidomide and Dexamethasone in Treatment of Transplant-Eligible Newly Diagnosed Multiple Myeloma Patients
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Multiple Myeloma
Related studies linked through entity extraction aliases.
A Study to Determine Final Geriatric Assessment in Haematology (GAH) Score as a Tool for Predicting Tolerance to Treatment in Elderly Patients (≥ 65 Years) With Haematologic Neoplasms
- Status
- COMPLETED
- Phase
- N/A
Long-Term Follow-Up Study of Subjects Treated With ACTR T Cell Product
- Status
- TERMINATED
- Phase
- N/A
A Study of Denosumab in Multiple Myeloma Patients With Renal Insufficiency
- Status
- COMPLETED
- Phase
- PHASE2
A Study to Test the Combination of Selinexor (KPT-330), Ixazomib, and Dexamethasone in Patients With Myeloma
- Status
- COMPLETED
- Phase
- PHASE1
Isatuximab Single Agent Study in Japanese Relapsed AND Refractory Multiple Myeloma Patients
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Study of Subcutaneous and Intravenous Velcade in Combination With Dexamethasone in Chinese Subjects With Relapsed and Refractory Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE3
A Study to Determine the Efficacy, Safety and Pharmacokinetics of GMI-1271 as Adjunct to Standard of Care for the Treatment of Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE1
A Study to Determine the Safety and Efficacy for the Combination of Durvalumab and Daratumumab in Relapsed and Refractory Multiple Myeloma
- Status
- TERMINATED
- Phase
- PHASE2
Induction Therapy for Multiple Myeloma With Carfilzomib, Lenalidomide,Dexamethasone,Panobinostat
- Status
- WITHDRAWN
- Phase
- PHASE1/PHASE2
Value of Macrophage-Colony Stimulating Factor as a New Marker of Bone Lesions in Multiple Myeloma
- Status
- COMPLETED
- Phase
- NA
Bortezomib as First Salvage Therapy for Myeloma Patients Previously Exposed to Bortezomib as Initial Treatment.
- Status
- UNKNOWN
- Phase
- N/A
CART-19 Post-ASCT for Multiple Myeloma
- Status
- TERMINATED
- Phase
- PHASE2
Vinorelbine and Gemcitabine in Myeloma
- Status
- COMPLETED
- Phase
- PHASE2
Identification of Hematological Malignancies and Therapy Predication Using microRNAs as a Diagnostic Tool
- Status
- UNKNOWN
- Phase
- N/A
Longterm Follow-up of Subjects Treated With bb2121
- Status
- COMPLETED
- Phase
- N/A
Study of Matched Unrelated Donor T Cell Infusion for Hematologic Malignancies After Allo-HSCT
- Status
- WITHDRAWN
- Phase
- PHASE1
Selinexor Plus High-Dose Melphalan (HDM) Before Autologous Hematopoietic Cell Transplantation for Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Treatment With a Scheme With Low Doses of Bortezomib / Melphalan / Prednisone (MPV) in Patients With Multiple Myeloma
- Status
- TERMINATED
- Phase
- PHASE4
A Study to Determine Dose, Safety, Tolerability and Efficacy of CC-220 Monotherapy, and in Combination With Other Treatments in Subjects With Multiple Myeloma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2